» Articles » PMID: 28637994

Anti-diabetic Activities of Traditional Chinese Herbal Medicine in Streptozotocin-induced Diabetic Rats

Overview
Date 2017 Jun 23
PMID 28637994
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Zhen Qi Hypoglycemic Capsules (ZQHC) is a traditional Chinese herbal medicine containing medical activities by ougi (Astragalus membranaceus) and ousei (Polygonatum rhizome). Although ZQHC has been traditionally utilized as an anti-diabetic medicine in China, there is no evidence. Therefore, this study investigated the beneficial effects of ZQHC against diabetes using streptozotocin (STZ)-induced diabetic rats by biochemical and morphological methods. Eight-week old male Fisher strain rats were intraperitoneally injected with STZ (50 mg/kg of B.W.) to induce diabetes and were fed ad lib feeding with normal diet containing 4% ZQHC for 30 days. Blood and urine samples were collected for biochemical analysis, and liver and pancreas samples were prepared for morphological analysis. Values of blood glucose, AST and ALT of ZQHC oral administrated diabetic rats were lower than those of diabetic rats without administration. Morphological analysis revealed that ZQHC induced sustainment of insulin secreted β cells survival and suppression of hepatocellular fat droplet accumulation. These results suggested that oral administration of ZQHC has anti-diabetic activities those were mainly associated with improvement of liver metabolism.

Citing Articles

Combination of and as Main Components in the Treatment of Diabetic Nephropathy: A Systematic Review and Meta-Analysis.

An X, Xu Y, Gui D Evid Based Complement Alternat Med. 2023; 2023:2945234.

PMID: 37101717 PMC: 10125758. DOI: 10.1155/2023/2945234.


An Ethnopharmaceutical Study on the Hypolipidemic Formulae in Taiwan Issued by Traditional Chinese Medicine Pharmacies.

Chi M, Chao J, Ko C, Huang S Front Pharmacol. 2022; 13:900693.

PMID: 36188612 PMC: 9520573. DOI: 10.3389/fphar.2022.900693.


Emerging Applications of Metabolomics to Assess the Efficacy of Traditional Chinese Medicines for Treating Type 2 Diabetes Mellitus.

Zhang Y, Yang Y, Ding L, Wang Z, Xiao Y, Xiao W Front Pharmacol. 2021; 12:735410.

PMID: 34603052 PMC: 8486080. DOI: 10.3389/fphar.2021.735410.


Targeting Oxidative Stress Reduction and Inhibition of HDAC1, MECP2, and NF-kB Pathways in Rats With Experimentally Induced Hyperglycemia by Administration of Willd. Extracts.

Sevastre-Berghian A, Ielciu I, Mitre A, Filip G, Oniga I, Vlase L Front Pharmacol. 2020; 11:581470.

PMID: 33071792 PMC: 7538623. DOI: 10.3389/fphar.2020.581470.


Uncovering the Mechanism of Astragalus membranaceus in the Treatment of Diabetic Nephropathy Based on Network Pharmacology.

Guo M, Dai Y, Gao J, Chen P J Diabetes Res. 2020; 2020:5947304.

PMID: 32215271 PMC: 7079250. DOI: 10.1155/2020/5947304.